KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsShares IssuedShares Outstanding
Ratios

NovoCure (NVCR) Long-Term Debt Repayments (2018 - 2024)

Historic Long-Term Debt Repayments for NovoCure (NVCR) over the last 7 years, with Q2 2024 value amounting to $12.9 million.

  • NovoCure's Long-Term Debt Repayments rose 43033333.33% to $12.9 million in Q2 2024 from the same period last year, while for Mar 2025 it was $12.9 million, marking a year-over-year increase of 43033333.33%. This contributed to the annual value of $12.9 million for FY2024, which is 12903000.0% up from last year.
  • Per NovoCure's latest filing, its Long-Term Debt Repayments stood at $12.9 million for Q2 2024, which was up 43033333.33% from $3000.0 recorded in Q2 2023.
  • Over the past 5 years, NovoCure's Long-Term Debt Repayments peaked at $150.0 million during Q3 2020, and registered a low of $3000.0 during Q2 2023.
  • For the 5-year period, NovoCure's Long-Term Debt Repayments averaged around $10.9 million, with its median value being $7000.0 (2020).
  • In the last 5 years, NovoCure's Long-Term Debt Repayments skyrocketed by 214285714.29% in 2020 and then crashed by 9999.6% in 2021.
  • Quarter analysis of 5 years shows NovoCure's Long-Term Debt Repayments stood at $6000.0 in 2020, then grew by 16.67% to $7000.0 in 2021, then changed by 0.0% to $7000.0 in 2022, then plummeted by 57.14% to $3000.0 in 2023, then skyrocketed by 430333.33% to $12.9 million in 2024.
  • Its Long-Term Debt Repayments stands at $12.9 million for Q2 2024, versus $3000.0 for Q2 2023 and $7000.0 for Q1 2023.